Breccia M, Olimpieri PP, Celant S, Olimpieri OM, et al. Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA). Ann Hematol 2023 Mar 13. doi: 10.1007/s00277-023-05168.
PMID: 36914888